1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
Ojha R, Huang HL, HuangFu WC, Wu YW, Nepali K, Lai MJ, Su CJ, Sung TY, Chen YL, Pan SL, Liou JP.
Ojha R, et al. Among authors: wu yw.
Eur J Med Chem. 2018 Apr 25;150:667-677. doi: 10.1016/j.ejmech.2018.03.006. Epub 2018 Mar 5.
Eur J Med Chem. 2018.
PMID: 29567459